Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
MERCK SHARP & DOHME LLC (MRK) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/04/2009 8-K Quarterly results
10/22/2009 8-K Quarterly results
Docs: "Merck Announces Third-Quarter 2009 Financial Results • Third-Quarter 2009 Non-GAAP EPS Increases 13 Percent to $0.90, Excluding Certain Items; Reports Third-Quarter GAAP EPS of $1.61, Including Gain from Merial Sale • Continued Growth of Key Products, JANUVIA, JANUMET, ISENTRESS and SINGULAIR, Drives Strong Results • Merck Updates Full-Year 2009 Non-GAAP EPS Range to $3.20 to $3.30, Excluding Certain Items, and 2009 GAAP EPS Range to $3.69 to $3.89 WHITEHOUSE STATION, N.J., Oct. 22, 2009 - Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP earnings per share for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-clo...",
"CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE"
09/21/2009 8-K Form 8-K - Current report
07/31/2009 8-K Form 8-K - Current report
07/21/2009 8-K Quarterly results
Docs: "Merck Announces Second-Quarter 2009 Financial Results • Merck Announces Second-Quarter 2009 Non-GAAP EPS of $0.83, Excluding Certain Items; Second-Quarter GAAP EPS of $0.74 • Company Results Driven by Solid Operational Performance with Significant Growth from Key Products SINGULAIR, JANUVIA, JANUMET and ISENTRESS • Merck Reaffirms Full-Year 2009 Non-GAAP EPS Range of $3.15 to $3.30, Excluding Certain Items; Reaffirms 2009 GAAP EPS Range of $2.84 to $3.09 WHITEHOUSE STATION, N.J., July 21, 2009 - Merck & Co., Inc. today announced financial results for the second quarter of 2009. The company reported non-GAAP earnings per share for the quarter of $0.83, which excludes $0.09 of restructuring charges and merger-related expenses. Second-quarter GAAP EPS was $0.74. Worldwide sales for the second...",
"CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE"
07/01/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "1.875% Notes due 2011 Officers' Certificate of the Company dated June 25, 2009, including form of the 2011 Notes",
"4.000% Notes due 2015 Officers' Certificate of the Company dated June 25, 2009, including form of the 2015 Notes",
"5.000% Notes due 2019 Officers' Certificate of the Company dated June 25, 2009, including form of the 2019 Notes",
"5.850% Notes due 2039 Officers' Certificate of the Company dated June 25, 2009, including form of the 2039 Notes"
06/25/2009 8-K Form 8-K -- Current report
06/22/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Awareness Letter of Deloitte & Touche LLP regarding Schering-Plough unaudited interim financial information",
"Consent of Deloitte & Touche LLP, independent registered public accounting firm for Schering-Plough",
"Schering-Plough audited historical consolidated financial statements and related notes as of December 31, 2008 and 2007 and for the years ended December 31, 2008, 2007 and 2006",
"Schering-Plough unaudited historical condensed consolidated financial statements and related notes as of March 31, 2009 and for the three months ended March 31, 2009 and 2008",
"Unaudited pro forma condensed combined financial information and related notes as of and for the three months ended March 31, 2009 and for the year ended December 31, 2008",
"Risk factors"
05/20/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Computation of Ratios of Earnings to Fixed Charges, as revised",
"Consent of Independent Registered Public Accounting Firm",
"Selected Items of the 2008 Annual Report on Form 10-K, as revised"
05/12/2009 8-K Form 8-K -- Current report
04/21/2009 8-K Form 8-K -- Current report
03/10/2009 8-K Form 8-K -- Current report
03/09/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "MERCK AND SCHERING-PLOUGH TO MERGE"
02/24/2009 8-K Form 8-K -- Current report
02/11/2009 8-K Form 8-K -- Current report
02/03/2009 8-K Form 8-K -- Current report
12/09/2008 8-K Form 8-K -- Current report
10/22/2008 8-K Quarterly results
Docs: "Merck Reports Third-Quarter 2008 Financial Results",
"CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE"
09/04/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
07/22/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Leslie A. “Les” Brun Elected to Merck Board of Directors"
07/21/2008 8-K Quarterly results
Docs: "Merck Reports Second-Quarter 2008 Financial Results",
"CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE"
04/21/2008 8-K Quarterly results
Docs: "Merck Reports First-Quarter 2008 Financial Results",
"CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE"
03/11/2008 8-K Other Events
03/03/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Stock option terms for a non-qualified stock option under the Merck & Co., Inc. 2007 Incentive Stock Plan",
"Restricted stock unit terms for annual grant under the Merck & Co., Inc. 2007 Incentive Stock Plan",
"Restricted stock unit terms for Leader Shares grant under the Merck & Co., Inc. 2007 Incentive Stock Plan",
"Performance share unit terms for annual grant under the Merck & Co., Inc. 2007 Incentive Stock Plan"
01/30/2008 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CERTAIN SUPPLEMENTAL INFORMATION"
12/18/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Harry Jacobson, M.D., Elected to Merck Board of Directors"
12/11/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Remarks given at the 2007 Annual Business Briefing by Richard T. Clark, Chairman of the Board, President and Chief Executive Officer of the Company",
"Annual Business Briefing Presentations given by certain senior executive officers of the Company on December 11, 2007"
11/27/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Thomas H. Glocer Elected to Merck Board of Directors"
11/14/2007 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Settlement Agreement, by and between the Company and The Counsel Listed on the Signature Pages Hereto, including the exhibits thereto"
10/22/2007 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CERTAIN SUPPLEMENTAL INFORMATION"
09/25/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Steven F. Goldstone Elected to Merck Board of Directors"
09/17/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
07/30/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
07/23/2007 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "SUPPLEMENTAL INFORMATION"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy